79 related articles for article (PubMed ID: 16442709)
1. The Syk tyrosine kinase: a new negative regulator in tumor growth and progression.
Coopman PJ; Mueller SC
Cancer Lett; 2006 Sep; 241(2):159-73. PubMed ID: 16442709
[TBL] [Abstract][Full Text] [Related]
2. Calling in SYK: SYK's dual role as a tumor promoter and tumor suppressor in cancer.
Krisenko MO; Geahlen RL
Biochim Biophys Acta; 2015 Jan; 1853(1):254-63. PubMed ID: 25447675
[TBL] [Abstract][Full Text] [Related]
3. Hypermethylation and prognostic implication of Syk gene in human colorectal cancer.
Yang Z; Huo L; Chen H; Ni B; Xiang J; Kang L; Wang L; Peng J; Yuan Y; Wang J
Med Oncol; 2013; 30(2):586. PubMed ID: 23609194
[TBL] [Abstract][Full Text] [Related]
4. Biochemical characterization of spleen tyrosine kinase (SYK) isoforms in platelets.
Kumar Singh P; Dangelmaier CA; Reddy Vari H; Tsygankov AY; Kunapuli SP
Platelets; 2023 Dec; 34(1):2249549. PubMed ID: 37661351
[TBL] [Abstract][Full Text] [Related]
5. Phase I study of novel SYK inhibitor TAK-659 (mivavotinib) in combination with R-CHOP for front-line treatment of high-risk diffuse large B-cell lymphoma.
Karmali R; St-Pierre F; Ma S; Foster KD; Kaplan J; Mi X; Pro B; Winter JN; Gordon LI
EJHaem; 2023 Feb; 4(1):108-114. PubMed ID: 36819145
[No Abstract] [Full Text] [Related]
6. Tumor cell SYK expression modulates the tumor immune microenvironment composition in human cancer via TNF-α dependent signaling.
Aguirre-Ducler A; Gianino N; Villarroel-Espindola F; Desai S; Tang D; Zhao H; Syrigos K; Trepicchio WL; Kannan K; Gregory RC; Schalper KA
J Immunother Cancer; 2022 Jul; 10(7):. PubMed ID: 35868661
[TBL] [Abstract][Full Text] [Related]
7. Analysis of SYK Gene as a Prognostic Biomarker and Suggested Potential Bioactive Phytochemicals as an Alternative Therapeutic Option for Colorectal Cancer: An In-Silico Pharmaco-Informatics Investigation.
Biswas P; Dey D; Rahman A; Islam MA; Susmi TF; Kaium MA; Hasan MN; Rahman MDH; Mahmud S; Saleh MA; Paul P; Rahman MR; Al Saber M; Song H; Rahman MA; Kim B
J Pers Med; 2021 Sep; 11(9):. PubMed ID: 34575665
[TBL] [Abstract][Full Text] [Related]
8. Comparison of SYK Signaling Networks Reveals the Potential Molecular Determinants of Its Tumor-Promoting and Suppressing Functions.
Buffard M; Naldi A; Freiss G; Deckert M; Radulescu O; Coopman PJ; Larive RM
Biomolecules; 2021 Feb; 11(2):. PubMed ID: 33670716
[TBL] [Abstract][Full Text] [Related]
9. Alcohol Intake and Alcohol-SNP Interactions Associated with Prostate Cancer Aggressiveness.
Lin HY; Wang X; Tseng TS; Kao YH; Fang Z; Molina PE; Cheng CH; Berglund AE; Eeles RA; Muir KR; Pashayan N; Haiman CA; Brenner H; Consortium TP; Park JY
J Clin Med; 2021 Feb; 10(3):. PubMed ID: 33540941
[TBL] [Abstract][Full Text] [Related]
10. Transcriptomics-Based Drug Repurposing Approach Identifies Novel Drugs against Sorafenib-Resistant Hepatocellular Carcinoma.
Regan-Fendt K; Li D; Reyes R; Yu L; Wani NA; Hu P; Jacob ST; Ghoshal K; Payne PRO; Motiwala T
Cancers (Basel); 2020 Sep; 12(10):. PubMed ID: 32977582
[No Abstract] [Full Text] [Related]
11. Systematic Analysis of Spleen Tyrosine Kinase Expression and its Clinical Outcomes in Various Cancers.
Alwithenani AI; Althubiti MA
Saudi J Med Med Sci; 2020; 8(2):95-104. PubMed ID: 32587490
[TBL] [Abstract][Full Text] [Related]
12. The Syk Kinase Promotes Mammary Epithelial Integrity and Inhibits Breast Cancer Invasion by Stabilizing the E-Cadherin/Catenin Complex.
Kassouf T; Larive RM; Morel A; Urbach S; Bettache N; Marcial Medina MC; Mèrezègue F; Freiss G; Peter M; Boissière-Michot F; Solassol J; Montcourrier P; Coopman P
Cancers (Basel); 2019 Dec; 11(12):. PubMed ID: 31817924
[TBL] [Abstract][Full Text] [Related]
13. Endocrine Resistance in Hormone Receptor Positive Breast Cancer-From Mechanism to Therapy.
Rani A; Stebbing J; Giamas G; Murphy J
Front Endocrinol (Lausanne); 2019; 10():245. PubMed ID: 31178825
[TBL] [Abstract][Full Text] [Related]
14. Expression of Syk and MAP4 proteins in ovarian cancer.
Zhang S; Deen S; Storr SJ; Yao A; Martin SG
J Cancer Res Clin Oncol; 2019 Apr; 145(4):909-919. PubMed ID: 30737623
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of spleen tyrosine kinase in human solid tumors.
Ni B; Li S; Liu Y; Huang Y; Li Z
Onco Targets Ther; 2018; 11():3377-3384. PubMed ID: 29922076
[TBL] [Abstract][Full Text] [Related]
16.
Zahavi T; Sonnenblick A; Shimshon Y; Kadouri L; Peretz T; Salmon AY; Salmon-Divon M
Cancer Manag Res; 2018; 10():589-598. PubMed ID: 29618939
[TBL] [Abstract][Full Text] [Related]
17. Activated spleen tyrosine kinase promotes malignant progression of oral squamous cell carcinoma via mTOR/S6 signaling pathway in an ERK1/2-independent manner.
Gao P; Qiao X; Sun H; Huang Y; Lin J; Li L; Wang X; Li C
Oncotarget; 2017 Oct; 8(48):83900-83912. PubMed ID: 29137391
[TBL] [Abstract][Full Text] [Related]
18. Tyrosine kinase 4 is involved in the reproduction of the platyhelminth parasite Schistosoma japonicum.
Ding H; Liu F; Zhu L; Wu F; Liu Q; He S; Shao W; Du Y; Ren C; Shen J; Liu M
Parasit Vectors; 2017 Oct; 10(1):498. PubMed ID: 29047397
[TBL] [Abstract][Full Text] [Related]
19. High mRNA expression of splice variant SYK short correlates with hepatic disease progression in chemonaive lymph node negative colon cancer patients.
Coebergh van den Braak RRJ; Sieuwerts AM; Kandimalla R; Lalmahomed ZS; Bril SI; van Galen A; Smid M; Biermann K; van Krieken JHJM; Kloosterman WP; Foekens JA; Goel A; Martens JWM; IJzermans JNM;
PLoS One; 2017; 12(9):e0185607. PubMed ID: 28957395
[TBL] [Abstract][Full Text] [Related]
20. Reconstruction and signal propagation analysis of the Syk signaling network in breast cancer cells.
Naldi A; Larive RM; Czerwinska U; Urbach S; Montcourrier P; Roy C; Solassol J; Freiss G; Coopman PJ; Radulescu O
PLoS Comput Biol; 2017 Mar; 13(3):e1005432. PubMed ID: 28306714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
